Patent · US Active

Methods of treating tumors in immune-privileged sites

US8741315B2 · kind B2 · utility

0Cited by
1References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 11, 2008
Grant dateJun 3, 2014
Priority date
Expiry dateOct 27, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/47
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating cancer in an immune-privileged site of a subject in need thereof is provided. The method comprises systemically administering to an area outside the immune-privileged site of the subject, a therapeutically effective amount of naive, viable cells of a tumor of the subject, the tumor being in the immune-privileged site so as to generate an immune response in the subject, thereby treating the cancer in the immune-privileged site of the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.